1. Home
  2. KHC vs NTRA Comparison

KHC vs NTRA Comparison

Compare KHC & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Kraft Heinz Company

KHC

The Kraft Heinz Company

HOLD

Current Price

$24.40

Market Cap

29.4B

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$212.12

Market Cap

32.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KHC
NTRA
Founded
1869
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Medical Specialities
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.4B
32.9B
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
KHC
NTRA
Price
$24.40
$212.12
Analyst Decision
Hold
Strong Buy
Analyst Count
15
14
Target Price
$26.13
$253.79
AVG Volume (30 Days)
15.5M
940.2K
Earning Date
05-14-2026
04-06-2026
Dividend Yield
6.67%
N/A
EPS Growth
N/A
59.52
EPS
N/A
N/A
Revenue
$24,942,000,000.00
$210,939,000.00
Revenue This Year
N/A
$34.18
Revenue Next Year
$0.41
$16.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.99
$125.38
52 Week High
$33.35
$256.36

Technical Indicators

Market Signals
Indicator
KHC
NTRA
Relative Strength Index (RSI) 49.27 45.24
Support Level $23.44 $204.04
Resistance Level $24.25 $220.65
Average True Range (ATR) 0.71 9.15
MACD -0.02 0.41
Stochastic Oscillator 38.92 49.48

Price Performance

Historical Comparison
KHC
NTRA

About KHC The Kraft Heinz Company

In July 2015, Kraft merged with Heinz to create one of North America's largest food and beverage manufacturers. Beyond its namesake brands, its portfolio includes Oscar Mayer, Velveeta, and Philadelphia. While the retail channel drives around 85% of its total sales, the firm also maintains a growing foodservice presence. Outside North America, Kraft Heinz's global reach encompasses a distribution network in Europe and emerging markets, which accounts for around 25% of its consolidated sales base. The company's products are sold in more than 190 countries and territories.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: